Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07380919
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07380919
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT07380919. Randomized; no masking; primary purpose treatment. Start 2026-02 (anticipated); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
- Acronym
- INaMICRON
- Condition
- STEMI (ST Elevation MI)
- Intervention (Drug)
- Ranolazine
- Lead sponsor
- Federico II University
- Collaborator
- Università Magna Grecia, Catanzaro
- Collaborator
- Santa Maria Goretti Hospital, Latina
Record details
- Record id
cardio:ct-nct07380919- Content hash
19cce98f459d83ed66866552c1fbd6fecaf4dba3b424a8f8a6861af4926d7b78